["Glucagon-like peptide I": a therapeutic alternative for diabetes mellitus?].
Fehmann
H C
HC
Zentrum für Innere Medizin, Universität Marburg.
Göke
B
B
D000818:Animals; D001402:B-Lymphocytes / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005934:Glucagon / Q000378:metabolism / Q000502:physiology / Q000627:therapeutic use*; D052216:Glucagon-Like Peptide 1; D000067757:Glucagon-Like Peptide-1 Receptor; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D010446:Peptide Fragments / Q000378:metabolism / Q000502:physiology / Q000627:therapeutic use*; D011498:Protein Precursors / Q000378:metabolism / Q000502:physiology / Q000627:therapeutic use*; D051381:Rats; D011956:Receptors, Cell Surface / Q000032:analysis; D018027:Receptors, Glucagon
C000593833:GLP1R protein, human; C000593835:Glp1r protein, rat; D000067757:Glucagon-Like Peptide-1 Receptor; D007328:Insulin; D010446:Peptide Fragments; D011498:Protein Precursors; D011956:Receptors, Cell Surface; D018027:Receptors, Glucagon; D052216:Glucagon-Like Peptide 1; D005934:Glucagon
"Glucagon-like peptide I": eine therapeutische Alternative bei Diabetes mellitus?